Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer
FLORENCE, Italy & HONG KONG--(BUSINESS WIRE)--Nov 7, 2023--The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and SciClone Pharmaceuticals (Holdings) Ltd. (“SciClone”), an international biopharmaceutical company, today announced ...
